|会社名||SVB Financial Group （SVBファイナンシャル・グル―プ）|
|概要||事業概要 エス・ヴィー・ビー・ファイナンシャル・グループ（SVB Financial Group）は金融サービス会社であり、銀行・金融持株会社でもある。同社はグローバル商業銀行事業、エス・ヴィー・ビー個人銀行事業及びエス・ヴィー・ビー・キャピタル事業の3つの事業区分により構成される。グローバル商業銀行事業は商業銀行、SVBワイン、SVBアナリティック、および債務基金投資の業務から構成される。エス・ヴィー・ビー個人銀行事業は同行のプライベート・バンキング部門であり、個人向け金融ソリューションを提供する。エス・ヴィー・ビー・キャピタル事業は主にファンドマネジメントに重点を置くSVBフィナンシャル・グループのベンチャーキャピタル投資部門である。同社は、子会社および事業部を通じて、米国内の顧客にバンキングおよび金融商品およびサービスを提供する。同社はテクノロジー、ライフサイエンス・ヘルスケア、プライベートエクイティ・ベンチャーキャピタル、ワイン産業におけるサービスを提供する。同行およびその子会社は、資産管理、プライベート・ウェルス・マネジメント、仲介およびその他の投資サービスも提供する。 SVBファイナンシャル・グル―プは米国の銀行・金融サ―ビス持株会社。主要子会社シリコン・バレ―・バンクを通じて、プライベ―トおよびコマ―シャルバンキングサ―ビスを提供。また、投資顧問、資産管理、個人財産管理、仲介サ―ビスのほか、資産運用サ―ビスも手掛ける。本社はカリフォルニア州サンタクララ。 For more than 35 years, SVB Financial Group and its subsidiaries have helped innovative companies and their investors move bold ideas forward, fast. SVB Financial Group's businesses, including Silicon Valley Bank, offer commercial and private banking, asset management, private wealth management, brokerage and investment services and funds management services to companies in the technology, life science and healthcare, private equity and venture capital, and premium wine industries. Headquartered in Santa Clara, California, SVB Financial Group operates in centers of innovation around the world.|
|本社所在地||3003 Tasman Drive Santa Clara CA 95054-1191 USA|
|代表者氏名||Roger F. Dunbar ロジャー・ダンバー|
|代表者役職名||Independent Chairman of the Board|
|市場名||NASDAQ National Market System|
|決算概要||決算概要 BRIEF: For the six months ended 30 June 2018 SVB Financial Group interest income increased 35% to $913.7M. Net interest income after loan loss provision increased 37% to $829.3M. Net income increased 93% to $432.8M. Net interest income after loan loss provision reflects Global Commercial Bank segment increase of 34% to $726.3M Net Interest Margin Total -% increase of 19% to 3.49%. Net income benefited from Gains on equity warrant assets.|
Benzinga''s Top Ratings Upgrades, Downgrades For May 4, 2022 2022/05/04 14:17:08 Benzinga
Upgrades Craig-Hallum upgraded the previous rating for Pros Holdings Inc (NYSE: PRO ) from Hold to Buy. Pros Holdings earned $0.21 in the first quarter, compared to $0.22 in the year-ago quarter. At the moment, the stock has a 52-week-high of $50.90 and a 52-week-low of $23.08. Pros Holdings closed at $28.64 at the end of the last trading period. For KAR Auction Services Inc (NYSE: KAR ), CJS Securities upgraded the previous rating of Market Perform to Market Outperform. KAR Auction Services earned $0.02 in the first quarter, compared to $0.45 in the year-ago quarter. The stock has a 52-week-high of $22.10 and a 52-week-low of $11.76. At the end of the last trading period, KAR Auction Services closed at $14.60. According to Argus Research, the prior rating for SVB Financial Group (NASDAQ: SIVB ) was changed from Hold to Buy. For the first quarter, SVB Finl Gr had an EPS of $7.92, compared to year-ago quarter EPS of $10.03. The stock has a 52-week-high of $763.22 and a 52-week-low of $479.10.
Benzinga''s Top Ratings Upgrades, Downgrades For May 3, 2022 2022/05/03 14:04:15 Benzinga
Upgrades For SVB Financial Group (NASDAQ: SIVB ), Oppenheimer upgraded the previous rating of Perform to Outperform. For the first quarter, SVB Finl Gr had an EPS of $7.92, compared to year-ago quarter EPS of $10.03. At the moment, the stock has a 52-week-high of $763.22 and a 52-week-low of $479.10. SVB Finl Gr closed at $497.67 at the end of the last trading period. Oppenheimer upgraded the previous rating for Morgan Stanley (NYSE: MS ) from Perform to Outperform. In the first quarter, Morgan Stanley showed an EPS of $2.06, compared to $2.22 from the year-ago quarter. At the moment, the stock has a 52-week-high of $109.73 and a 52-week-low of $80.03. Morgan Stanley closed at $81.96 at the end of the last trading period. According to Oppenheimer, the prior rating for JPMorgan Chase & Co (NYSE: JPM ) was changed from Perform to Outperform. For the first quarter, JPMorgan Chase had an EPS of $2.63, compared to year-ago quarter EPS of $4.50. The stock has a 52-week-high of $172.96 and a 52-week-low of $118.22.
Oppenheimer upgrades JPM, Morgan Stanley, SVB Financial on rising interest rates and loan growth 2022/05/03 13:50:25 MarketWatch
Oppenheimer analyst Chris Kotowski on Tuesday upgraded shares of Dow Jones Industrial Average JPMorgan Chase & Co. to outperform from perform, along with Morgan Stanley and SVB Financial Group . Each of those three names has a 30%-plus upside potential in the next 12 to 18 months, after pullbacks in their stock prices and are benefitting from loan growth and higher interest rates, he said. "Investors should take advantage of this weakness," Kotowski said. He noted that bank stocks started the year in positive territory before jitters about a recession and the war in Ukraine took hold, despite current strength in the economy and rising interest rates that typically boost bank earnings. "Why upgrade three stocks now when there is more ''uncertainty'' in the world?," Kotowski said. "In our view, the world is always uncertain, and there are just times when more people are worried about it, and this is one of those times. But the simple reality is that we have raised our earnings estimates for all three of the companies that we are upgrading during this earnings season, and all three are down more than the S&P 500 and the KBW Nasdaq Bank Index." Shares of JPMorgan rose 1.1%, while Morgan Stanley advanced by 1.6% and SVB Financial Group tacked on 1.4%.
JPMorgan, Morgan Stanley, SVB Financial upgraded to Outperform at Oppenheimer (NYSE:JPM) 2022/05/03 11:56:41 Seeking Alpha
Oppenheimer analyst Chris Kotowski upgraded JPMorgan Chase (JPM), Morgan Stanley (MS), and SVB Financial (SIVB) to Outperform from Perform as the banking sector, overall, has…
Alexandria Real Estate Equities, Inc., at the Vanguard of the Life Science Industry, Reports: 1Q22 Net Loss per Share - Diluted of $0.96; 1Q22 FFO per Share - Diluted, As Adjusted, of $2.05 2022/04/25 20:10:00 Benzinga
PASADENA, Calif. , April 25, 2022 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE ) announced financial and operating results for the first quarter ended March 31, 2022 . Key highlights Operating results 1Q22 1Q21 Total revenues: In millions $ 615.1 $ 479.8 Growth 28.2% Net (loss) income attributable to Alexandria''s common stockholders – diluted In millions $ (151.7) $ 6.1 Per share $ (0.96) $ 0.04 Funds from operations attributable to Alexandria''s common stockholders – diluted, as adjusted In millions $ 324.6 $ 263.0 Per share $ 2.05 $ 1.91 Continued strong leasing volume in 1Q22, after a historic year of leasing in 2021 Strong leasing activity continued in 1Q22 with the second-highest leasing volume in Company history for both total space and development and redevelopment space: 1Q22 Total leasing activity – RSF 2,463,438 Leasing of development and redevelopment space – RSF 1,439,696 Lease renewals and re-leasing of space: RSF (included in total leasing activity above) 864,077 Rental rate increases 32.2% Rental rate increases (cash basis) 16.5% Excluding short-term renewals executed to allow Bristol-Myers Squibb Company ("BMS") to expand and consolidate into our Alexandria Point development project, described further below: Rental rate increases 39.8% Rental rate increases (cash basis) 23.2% During 1Q22, we executed the following long-term leases: 426,927 RSF with BMS, our largest tenant, for the development of BMS''s newest innovative cutting-edge research hub focused on cancer as well as immune-mediated and neurodegenerative diseases at the Alexandria Point mega campus in San Diego . 333,929 RSF with Eli Lilly and Company ("Lilly"), our third largest tenant, for the development of Lilly''s new state-of-the-art Institute for Genetic Medicine at 15 Necco Street in our Seaport Innovation District submarket of Greater Boston .
Q4 2021 Earnings Estimate for GlaxoSmithKline plc Issued By SVB Leerink (NYSE:GSK) 2021/11/01 06:58:41 Dakota Financial News
GlaxoSmithKline plc (NYSE:GSK) Equities research analysts at SVB Leerink raised their Q4 2021 earnings per share (EPS) estimates for shares of GlaxoSmithKline in a research note issued on Thursday, October 28th. SVB Leerink analyst G. Porges now expects that the pharmaceutical company will post earnings of $0.77 per share for the quarter, up from 
Q4 2021 EPS Estimates for Thermo Fisher Scientific Inc. Increased by SVB Leerink (NYSE:TMO) 2021/11/01 06:52:41 Dakota Financial News
Thermo Fisher Scientific Inc. (NYSE:TMO) SVB Leerink lifted their Q4 2021 earnings per share (EPS) estimates for Thermo Fisher Scientific in a research note issued to investors on Wednesday, October 27th. SVB Leerink analyst P. Souda now forecasts that the medical research company will post earnings of $4.82 per share for the quarter, up 
Amalgamated Bank Has $9.30 Million Stock Position in SVB Financial Group (NASDAQ:SIVB) 2021/10/31 12:14:44 Dakota Financial News
Amalgamated Bank grew its stake in SVB Financial Group (NASDAQ:SIVB) by 494.1% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 16,713 shares of the banks stock after purchasing an additional 13,900 shares during the quarter. Amalgamated Banks holdings in SVB Financial 
Corient Capital Partners LLC Buys 107 Shares of SVB Financial Group (NASDAQ:SIVB) 2021/10/30 16:48:43 Dakota Financial News
Corient Capital Partners LLC lifted its stake in SVB Financial Group (NASDAQ:SIVB) by 11.3% in the second quarter, Holdings Channel.com reports. The fund owned 1,057 shares of the banks stock after purchasing an additional 107 shares during the period. Corient Capital Partners LLCs holdings in SVB Financial Group were worth $588,000 as of its most 
SVB Financial Group (NASDAQ:SIVB) Price Target Raised to $775.00 2021/10/30 13:02:58 Dakota Financial News
SVB Financial Group (NASDAQ:SIVB) had its target price upped by Morgan Stanley from $625.00 to $775.00 in a report released on Wednesday morning, Price Targets.com reports. The firm currently has an equal weight rating on the banks stock. Several other analysts have also recently commented on the company. Wells Fargo & Company increased their target 
Howard Dingle Joins SVB Leerinks Healthcare Services Practice to Enhance Distribution, Technology, and Related Services Offerings 2021/06/30 10:05:00 Stocks News Feed
BOSTON, June 30, 2021 /PRNewswire/ SVB Leerink, a leading investment bank specializing in healthcare and life sciences, announced today that Howard Dingle has joined the firms Healthcare Services practice to enhance its distribution, technology, and related services offerings. Mr. Dingle joins SVB Leerink as a Managing Director reporting to Global Co-Head of Healthcare Investment Banking, Read More » Howard Dingle Joins SVB Leerinks Healthcare Services Practice to Enhance Distribution, Technology, and Related Services Offerings The post Howard Dingle Joins SVB Leerinks Healthcare Services Practice to Enhance Distribution, Technology, and Related Services Offerings appeared on Stocks News Feed .
Howard Dingle Joins SVB Leerink''s Healthcare Services Practice to Enhance Distribution, Technology, and Related Services Offerings 2021/06/30 10:05:00 Benzinga
BOSTON , June 30, 2021 /PRNewswire/ -- SVB Leerink, a leading investment bank specializing in healthcare and life sciences, announced today that Howard Dingle has joined the firm''s Healthcare Services practice to enhance its distribution, technology, and related services offerings. Mr. Dingle joins SVB Full story available on Benzinga.com
ShipBob joins the unicorn club with $200M Series E funding 2021/06/29 21:45:08 The Real Deal
ShipBob, a logistics company that provides shipping and delivery services for e-commerce companies, raised another $200 million in funding, taking the company to virtual unicorn status. The Chicago-based firm raised the money in a rare Series E round led by Bain Capital Venture, which has been investing in the 7-year-old business since 2017. Softbank, Menlo Ventures, Hyde Park Venture Partners, Hyde Park Angels and Silicon Valley Bank also participated in the round that pushed ShipBobs The post ShipBob joins the unicorn club with $200M Series E funding appeared first on The Real Deal New York .
Cortica Raises $60M in Series C Funding 2021/06/29 18:41:41 FinSMEs
Cortica, a San Diego CA-based company focused on clinical services for autism and other neurodevelopmental conditions, raised $60M in series C funding. The round was led by Longitude Capital with participation from 406 Ventures, Adam Boehler, Questa Capital and Aperture Venture Partners and Silicon Valley Bank, which expanded Corticas credit facilities. As part of the financing, Cortica is  The post Cortica Raises $60M in Series C Funding appeared first on FinSMEs .
Global Fulfillment Startup ShipBob Notches $200M Series E 2021/06/29 15:23:12 PYMNTS
Global eCommerce fulfillment startup ShipBob has raised $200 million in a Series E funding round led by Bain Capital Ventures, with participation from previous backers including SoftBank, Menlo Ventures, Hyde Park Venture Partners, Hyde Park Angels and Silicon Valley Bank. The fastest-growing eCommerce brands recognize that world-class fulfillment increases revenue and builds customer loyalty, Ajay